1. Home
  2. ATHE vs UGRO Comparison

ATHE vs UGRO Comparison

Compare ATHE & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • UGRO
  • Stock Information
  • Founded
  • ATHE 1997
  • UGRO 2014
  • Country
  • ATHE Australia
  • UGRO United States
  • Employees
  • ATHE N/A
  • UGRO N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • UGRO Industrial Specialties
  • Sector
  • ATHE Health Care
  • UGRO Consumer Discretionary
  • Exchange
  • ATHE Nasdaq
  • UGRO Nasdaq
  • Market Cap
  • ATHE 11.1M
  • UGRO 18.0M
  • IPO Year
  • ATHE N/A
  • UGRO N/A
  • Fundamental
  • Price
  • ATHE $1.20
  • UGRO $1.60
  • Analyst Decision
  • ATHE Buy
  • UGRO Strong Buy
  • Analyst Count
  • ATHE 1
  • UGRO 2
  • Target Price
  • ATHE $4.00
  • UGRO $5.63
  • AVG Volume (30 Days)
  • ATHE 13.3K
  • UGRO 26.1K
  • Earning Date
  • ATHE 10-29-2024
  • UGRO 11-07-2024
  • Dividend Yield
  • ATHE N/A
  • UGRO N/A
  • EPS Growth
  • ATHE N/A
  • UGRO N/A
  • EPS
  • ATHE N/A
  • UGRO N/A
  • Revenue
  • ATHE $2,681,669.00
  • UGRO $70,320,066.00
  • Revenue This Year
  • ATHE N/A
  • UGRO $14.76
  • Revenue Next Year
  • ATHE N/A
  • UGRO $21.29
  • P/E Ratio
  • ATHE N/A
  • UGRO N/A
  • Revenue Growth
  • ATHE 2.63
  • UGRO 12.08
  • 52 Week Low
  • ATHE $1.01
  • UGRO $1.02
  • 52 Week High
  • ATHE $5.41
  • UGRO $2.84
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 39.10
  • UGRO 66.33
  • Support Level
  • ATHE $1.20
  • UGRO $1.39
  • Resistance Level
  • ATHE $1.32
  • UGRO $1.49
  • Average True Range (ATR)
  • ATHE 0.08
  • UGRO 0.10
  • MACD
  • ATHE -0.01
  • UGRO 0.02
  • Stochastic Oscillator
  • ATHE 0.00
  • UGRO 100.00

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Share on Social Networks: